Results 131 to 140 of about 42,544 (264)
Background/Aims: We aimed to investigate the clinical importance of quantitative levels of serum hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg), and to detect their correlation with hepatitis B virus (HBV) DNA load, alanine ...
Kaan Demirören +2 more
doaj +1 more source
An Exploratory Cost‐Utility Analysis of Screening and Treating Immigrants in Canada for Hepatitis D
ABSTRACT Hepatitis D is common among immigrants in Canada, who account for approximately 23% of the population and tend to originate from high‐endemic countries. Mortality rates are notably high among those with chronic infections, and immigrants are less likely to engage in screening and treatment services.
Jiahao Zhao +4 more
wiley +1 more source
Hepatitis B virus (HBV) covalently closed circular (ccc) DNA is essential to the virus life cycle, its elimination during chronic infection is considered critical to a durable therapy but has not been achieved by current antivirals.
Dawei Cai +7 more
semanticscholar +1 more source
Introduction: Chronic hepatitis B (CHB) is associated with high burden and healthcare costs. Virologic response achieved with an-tivirals is associated with progression avoidance.
Itziar Oyagüez +4 more
doaj +1 more source
Impact of HBeAg on the maturation and function of dendritic cells.
OBJECTIVES HBV infection typically leads to chronic hepatitis in newborns and some adults with weakened immune systems. The mechanisms by which virus escapes immunity remain undefined.
S. Lan +6 more
semanticscholar +1 more source
A novel nomogram for predicting HBeAg seroclearance in HBeAg-positive chronic hepatitis B patients treated with nucleos(t)ide analogues [PDF]
Introduction and Objectives: Seroclearance of hepatitis B e antigen (HBeAg) is an important treatment goal for patients with chronic hepatitis B (CHB).
Yan Gu +13 more
core +1 more source
Objective The investigation regarding the clinical significance of quantitative hepatitis B core antibody (anti-HBc) during chronic hepatitis B (CHB) treatment is limited.
R. Fan +22 more
semanticscholar +1 more source
To identify the prevalence of hepatitis B e antigen (HBeAg) and to assess the association of hepatitis B virus (HBV) core promoter mutations and viral load in Indonesian patients.Sixty-four patients with chronic hepatitis, 65 with liver cirrhosis and 50 with hepatocellular carcinoma were included in this study.
Andi, Utama +16 more
openaire +2 more sources
Factors associated with HBeAg seroconversion plus HBV DNA <2000 IU/mL 12 months post-treatment in treatment experienced HBeAg-positive CHB patients. [PDF]
Continuous variables: median (25th, 75th percentiles); categorical variables: numbers(percentages)IFN: interferon; ALT: alanine aminotransferase; ULN: upper limit of normal; HBeAg: hepatitis B e antigen; HBsAg: hepatitis B surface antigenFactors ...
Jee-Fu Huang (292609) +10 more
core +1 more source
Background: Hepatitis B virus (HBV) infection is a serious public health issue that must be addressed. Aim: The goal of this study was to investigate the correlation between serological status for hepatitis Be antigen (HBeAg)/anti-HBe, serum transaminase
Manoj Kumar +6 more
doaj +1 more source

